Том 42 № 2 (2020): Експериментальна онкологія

Відгуки

Human microbiota and effectiveness of cancer chemotherapy

Yu.V. Shvets, N.Yu. Lukianova, V.F. Chekhun

82-93
- PDF (English)
DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14611

Оригінальні внески

NANOG as prognostic factor of prostate cancer course

T.V. Zadvornyi, N.Yu. Lukianova, T.V. Borikun, Yu.V. Vitruk, E.O. Stakhovsky, V.F. Chekhun

94-100
- PDF (English)
DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14673
Anti-proliferative effects of a blueberry extract on a panel of tumor cell lines of different origin

H. Lamdan, R.S. Garcia-Lazaro, N. Lorenzo, L.G. Caligiuri, D.F. Alonso, H.G. Farina

101-108
- PDF (English)
DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14766
Inhibition of USP1, a new partner of Bcr-Abl, results in decrease of Bcr-Abl level in K562 cells

S.V. Antonenko, G.D. Telegeev

109-114
- PDF (English)
DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14533
Expression of micro-RNA hsa-miR-30c-5p and hsa-miR-138-1 in renal cell carcinoma

K.V. Onyshchenko, T.V. Voitsitskyi, V.M. Grygorenko, N.O. Saidakova, L.V. Pereta, A.P. Onyschuk, I.Ya. Skrypkina

115-119
- PDF (English)
DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14632
Conjugation of new DNA vaccine with polyethylenimine induces cellular immune response and tumor regression in neuroblastoma mouse model

M.V. Stegantseva, V.A. Shinkevich, E.M. Tumar, A.N. Meleshko

120-125
- PDF (English)
DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14473
Peculiarities of abnormal karyotypes formation in therapy-related acute leukemias

S.V. Andreieva, O.A. Kyselova, I.M. Serbin, O.G. Alkhimova

126-129
- PDF (English)
DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14593
HRM screening of the UBC9 gene encoding the SUMO-E2-conjugating enzyme — case-control study in breast cancer

P. Bialik, D. Wysokinski, M. Slomka, Z. Morawiec, D. Strapagiel, K. Wozniak

130-134
- PDF (English)
DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14739
Clinicopathological correlation of the expression of excision repair cross complementation group 1 (ERCC1) in oral cavity squamous cell carcinomas: an immunohistochemical study

D. Pankaj, V. Guddattu, M.C. Solomon

135-139
- PDF (English)
DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14461
Prognostic role of androgen receptor expression in patients with metastatic triple negative breast cancer

S.A. Lyalkin, N.O. Verevkina, O.O. Alekseyenko, L.A. Syvak

140-143
- PDF (English)
DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14579
Expression of Ki-67 and CD34 on blood and bone marrow cells of CML patients with different response to imatinib and nilotinib therapy

T. Perekhrestenko, U. Melnyk, N. Goryainova, I. Diagil

144-147
- PDF (English)
DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14497
Temozolomide in glioblastoma treatment: 15-year clinical experience and analysis of its efficacy

O.Ya. Glavatskyi, O.V. Zemskova, H.V. Khmelnytskyi, K.A. Kardash, I.M. Shuba, V.A. Stuley

148-156
- PDF (English)
DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14503

Социальные аспекты онкологической помощи

Specialized care provided to patients with rectal cancer in Kyiv city

O.M. Kliusov

157-160
- PDF (English)
DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14560

Відгуки

Human microbiota and effectiveness of cancer chemotherapy

Оригінальні внески

NANOG as prognostic factor of prostate cancer course

Anti-proliferative effects of a blueberry extract on a panel of tumor cell lines of different origin

Inhibition of USP1, a new partner of Bcr-Abl, results in decrease of Bcr-Abl level in K562 cells

Expression of micro-RNA hsa-miR-30c-5p and hsa-miR-138-1 in renal cell carcinoma

Conjugation of new DNA vaccine with polyethylenimine induces cellular immune response and tumor regression in neuroblastoma mouse model

Peculiarities of abnormal karyotypes formation in therapy-related acute leukemias

HRM screening of the UBC9 gene encoding the SUMO-E2-conjugating enzyme — case-control study in breast cancer

Clinicopathological correlation of the expression of excision repair cross complementation group 1 (ERCC1) in oral cavity squamous cell carcinomas: an immunohistochemical study

Prognostic role of androgen receptor expression in patients with metastatic triple negative breast cancer

Expression of Ki-67 and CD34 on blood and bone marrow cells of CML patients with different response to imatinib and nilotinib therapy

Temozolomide in glioblastoma treatment: 15-year clinical experience and analysis of its efficacy

Социальные аспекты онкологической помощи

Specialized care provided to patients with rectal cancer in Kyiv city

Мова

Подати статтю